Aspen Aerogels (NYSE:ASPN) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Posted by Brian Himes on Aug 7th, 2026

Aspen Aerogels (NYSE:ASPN – Get Free Report) announced its earnings results on Thursday. The construction company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01, Zacks reports. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 29.30%. The company had revenue of $49.85 million during the quarter, compared to the consensus estimate of $42.42 million. Aspen Aerogels updated its Q3 2026 guidance to -0.110–0.070 EPS.

Here are the key takeaways from Aspen Aerogels’ conference call:

Q3 outlook improved significantly, with revenue expected at $65 million–$80 million and adjusted EBITDA of $7 million–$15 million, supported by stronger energy industrial deliveries and higher thermal-barrier demand.
Energy Industrial remains on track for approximately 20% growth in 2026, driven by LNG and subsea projects; management expects additional growth in 2027 and is targeting a $200 million, high-margin business without significant incremental capital investment.
European PyroThin momentum accelerated, including a new Jaguar Land Rover design award. Aspen raised its 2026 European thermal-barrier revenue outlook to $20 million–$30 million from $10 million–$15 million and is targeting $40 million–$60 million in 2027.
Aspen has begun a staged restart of its East Providence facility and expects full production capacity to return in the first half of 2027. Insurance is expected to recover a significant portion of incident-related costs, but expedited freight, external manufacturing, professional fees, and restoration spending will continue to pressure results and cash flow.
Battery energy storage systems are being developed as a third growth segment, with customer qualification programs and commercial discussions underway. Management expects initial revenue in the near term but is not assuming meaningful BESS revenue in 2026.

Aspen Aerogels Stock Performance

ASPN stock traded down $0.62 during mid-day trading on Friday, hitting $6.26. The company had a trading volume of 2,296,212 shares, compared to its average volume of 1,620,230. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.54 and a current ratio of 2.89. The firm has a market cap of $519.24 million, a PE ratio of -4.09 and a beta of 2.99. Aspen Aerogels has a 12 month low of $2.30 and a 12 month high of $9.35. The stock’s fifty day moving average price is $5.51 and its two-hundred day moving average price is $4.42.

More Aspen Aerogels News

Here are the key news stories impacting Aspen Aerogels this week:

Positive Sentiment: Aspen reported second-quarter revenue of $49.85 million, exceeding the $42.42 million consensus estimate. Its adjusted loss of $0.22 per share was also slightly better than the expected $0.23 loss. Aspen Aerogels Reports Q2 Loss, Beats Revenue Estimates
Positive Sentiment: Thermal Barrier revenue reached $29.5 million, an 81% sequential increase, highlighting momentum in Aspen’s electrification-related business. The company also raised its 2026 European Thermal Barrier revenue outlook to $20 million-$30 million. Aspen Aerogels Second-Quarter Results
Positive Sentiment: Third-quarter revenue guidance of $65 million-$80 million is well above the $56.6 million analyst consensus, while adjusted EBITDA guidance of $7 million-$15 million suggests improving operating leverage. EPS guidance of a $0.07-$0.11 loss is also better than the expected $0.13 loss. Aspen Aerogels Guidance
Positive Sentiment: Jaguar Land Rover selected Aspen’s PyroThin technology for two next-generation vehicle architectures, adding evidence of potential future automotive demand. Q2 2026 Earnings Presentation
Neutral Sentiment: Aspen Aerogels’ inclusion in Russell 1000 coverage may improve visibility and potentially attract index-related investor interest, although the direct financial impact is uncertain. Aspen Aerogels Russell 1000 News
Negative Sentiment: The company remains unprofitable: its second-quarter loss widened from $0.04 per share a year earlier to $0.22, with negative net margin and return on equity. This continuing cash-burn and execution risk may be limiting the market’s reaction to the otherwise favorable results. Aspen Aerogels Q2 Earnings Snapshot

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wall Street Zen upgraded shares of Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. B. Riley Financial reaffirmed a “buy” rating on shares of Aspen Aerogels in a report on Friday. Roth Capital reaffirmed a “buy” rating and set a $7.75 price target on shares of Aspen Aerogels in a research report on Friday. Finally, Barclays lifted their price target on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a report on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $5.69.

Read Our Latest Analysis on Aspen Aerogels

Institutional Investors Weigh In On Aspen Aerogels

Large investors have recently modified their holdings of the stock. Raymond James Financial Inc. raised its position in shares of Aspen Aerogels by 6.8% during the 2nd quarter. Raymond James Financial Inc. now owns 26,559 shares of the construction company’s stock valued at $157,000 after buying an additional 1,687 shares in the last quarter. Legal & General Group Plc lifted its holdings in shares of Aspen Aerogels by 3.6% during the 2nd quarter. Legal & General Group Plc now owns 67,130 shares of the construction company’s stock worth $397,000 after acquiring an additional 2,324 shares during the last quarter. Osaic Holdings Inc. grew its position in Aspen Aerogels by 29.1% in the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company’s stock worth $63,000 after acquiring an additional 2,390 shares in the last quarter. The Manufacturers Life Insurance Company grew its position in Aspen Aerogels by 12.1% in the second quarter. The Manufacturers Life Insurance Company now owns 24,671 shares of the construction company’s stock worth $146,000 after acquiring an additional 2,656 shares in the last quarter. Finally, Deutsche Bank AG increased its stake in Aspen Aerogels by 1.3% in the fourth quarter. Deutsche Bank AG now owns 223,093 shares of the construction company’s stock valued at $631,000 after acquiring an additional 2,880 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.